CD8A and neoplasm: Among them, CD8+ TILs were associated with favorable outcomes and played an important role in cell-mediated antitumor response and were associated with favorable outcomes [10, 11], whereas tumor-infiltrating FOXP3+ Tregs were thought to have inhibitory effects on antitumor immunity and correlated to a worse prognosis in lung cancer patients [12].